This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.86% per year. These returns cover a period from January 1, 1988 through February 2, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
Zacks News
All-World Low Volatility ETF (ACWV) Hits New 52-Week High
by Sanghamitra Saha
This all-world low volatility ETF hit a 52-week high lately. can it soar higher?
Bet on Low-Volatility ETFs to Combat Rising Delta Variant Scares
by Sweta Jaiswal, FRM
Low-volatility products could be fascinating picks for those seeking steady investment in equities amid current market volatility.
Low-Volatility ETFs to the Rescue Amid Rising Market Uncertainty
by Sweta Jaiswal, FRM
Low-volatility products could be fascinating picks for those seeking steady investment in equities amid current market volatility.
The Zacks Analyst Blog Highlights: USMV, SPLV, EFAV, ACWV and SPHD
by Zacks Equity Research
The Zacks Analyst Blog Highlights: USMV, SPLV, EFAV, ACWV and SPHD
Here's Why It's Wise to Invest in Low Volatility ETFs Now
by Sweta Jaiswal, FRM
Low-volatility products could be sensible choices for those who want to continue investing in equities in turbulent market conditions.
Opt for Minimum Volatility ETFs Amid Latest Covid-19 Worries
by Sweta Jaiswal, FRM
Given the latest spike in coronavirus cases and chances of another round of lockdown, it is a wise idea for investors to opt for low-volatility products.
American Century Investments Launches Low Volatility ETF (LVOL)
by Sweta Jaiswal, FRM
Low Volatility ETF (LVOL) from the house of American Century Investments seeks to track the market over long term, while realizing less volatility, particularly during downturns.
ETFs to Counter Georgia Senate Runoffs-Induced Volatility
by Sweta Jaiswal, FRM
Given the spike in coronavirus outbreak and uncertainty surrounding the Senate run-off elections in Georgia, it seems investors might opt for low-volatility products.
Defensive ETF Strategies to Sail Through Soaring COVID-19 Cases
by Sweta Jaiswal, FRM
Let's look at some safer ETF strategies that investors can play amid the rising fears regarding another round of coronavirus-led lockdowns.
ETFs to Minimize Volatility Amid Pausing Coronavirus Trials
by Sweta Jaiswal, FRM
Given the spike in coronavirus outbreak, dampened hopes of another economic stimulus and suspended vaccine and treatment trials, it seems investors might take refuge in low-volatility products.